Advertisement

Caution Urged on SARS Vaccines

Science13 Feb 2004Vol 303, Issue 5660pp. 944-946DOI: 10.1126/science.303.5660.944
Get full access to this article

View all available purchase options and get full access to this article.

Already a Subscriber?

Information & Authors

Information

Published In

Science
Volume 303Issue 566013 February 2004
Pages: 944 - 946

Permissions

Request permissions for this article.

Authors

Affiliations

Eliot Marshall
With reporting by Dennis Normile in Tokyo and Ding Yimin in Beijing.
Martin Enserink
With reporting by Dennis Normile in Tokyo and Ding Yimin in Beijing.

Metrics & Citations

Metrics

Citations

View Options

Media

Figures

Other

Tables

Share

Information & Authors
Published In
issue cover image
Science
Volume 303|Issue 5660
13 February 2004
Submission history
Published in print:13 February 2004
Metrics & Citations
Article usage
Altmetrics
Export citation

Select the format you want to export the citation of this publication.

Cited by
  1. Drug-Nutrition Interactions in Infectious Diseases, Nutrition and Infectious Diseases, (367-410), (2021).https://doi.org/10.1007/978-3-030-56913-6
    Crossref
  2. Vaccines for COVID‐19, Clinical & Experimental Immunology, 202, 2, (162-192), (2020).https://doi.org/10.1111/cei.13517
    Crossref
  3. COVID-19 human challenge studies: ethical issues, The Lancet Infectious Diseases, 20, 8, (e198-e203), (2020).https://doi.org/10.1016/S1473-3099(20)30438-2
    Crossref
  4. Antiviral nanoagents: More attention and effort needed?, Nano Today, 35, (100976), (2020).https://doi.org/10.1016/j.nantod.2020.100976
    Crossref
  5. Receptor-binding domains of spike proteins of emerging or re-emerging viruses as targets for development of antiviral vaccines, Emerging Microbes & Infections, 1, 1, (1-8), (2019).https://doi.org/10.1038/emi.2012.1
    Crossref
  6. MERS-CoV: Understanding the Latest Human Coronavirus Threat, Viruses, 10, 2, (93), (2018).https://doi.org/10.3390/v10020093
    Crossref
  7. Vaccine Development Against Middle East Respiratory Syndrome, Current Tropical Medicine Reports, 3, 3, (80-86), (2016).https://doi.org/10.1007/s40475-016-0084-0
    Crossref
  8. Overview of antiviral and anti-inflammatory treatment for severe acute respiratory syndrome, Expert Review of Anti-infective Therapy, 3, 2, (251-262), (2014).https://doi.org/10.1586/14787210.3.2.251
    Crossref
  9. Novel and re-emerging respiratory infections, Expert Review of Anti-infective Therapy, 2, 3, (405-412), (2014).https://doi.org/10.1586/14787210.2.3.405
    Crossref
  10. Neutralizing human monoclonal antibodies to severe acute respiratory syndrome coronavirus: target, mechanism of action, and therapeutic potential, Reviews in Medical Virology, 22, 1, (2-17), (2011).https://doi.org/10.1002/rmv.706
    Crossref
Loading...
Share
Share article link

Share on social media
Get Access
Log in to view the full text

AAAS Log in

AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions, as well as limited access for those who register for access.

Log in via OpenAthens.
Log in via Shibboleth.
More options

Purchase digital access to this article

Download and print this article for your personal scholarly, research, and educational use.

Purchase this issue in print

Buy a single issue of Science for just $15 USD.

View Options
Tables
References

(0)eLetters

No eLetters have been published for this article yet.

eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. eLetters are not edited, proofread, or indexed. Please read our Terms of Service before submitting your own eLetter.